Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1a/1b study of INCB081776 in advanced malignancies
NL-OMON60764Phase 1Completed
- Sponsor
- Incyte
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of INCB081776 in Non-hematologic malignancy and hematopoietic malignancies, sponsored by Incyte. Primary endpoint: Primary endpoint(s). Started Sep 2022; status: completed.
02
Drugs
INCB081776
03
Conditions
Non-hematologic malignancyhematopoietic malignancies
Beyond the preview
Go deeper on NL-OMON60764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60764.